Return to Alcohol Use After Liver Transplant: Who Is at Risk?
BACKGROUND Alcohol-associated liver disease remains the leading indication for liver transplant (LT), yet there has been limited analysis of what psychosocial factors correlate with biomarker-confirmed return to alcohol use in the post-LT setting. MATERIAL AND METHODS We conducted a single-center, retrospective, cohort study of all adult patients with alcohol-associated liver disease who received a liver transplant (LT) between 2016 and 2022. Medical records were queried for demographics, psychosocial variables, pre-LT sobriety duration, and 1-year post-LT mortality. Logistic regression and time-to-event analysis was used to correlate these factors with post-LT biomarker-confirmed return to alcohol use, defined as at least 1 positive urine ethyl glucuronide, urine ethyl sulfate, or serum phosphatidylethanol. RESULTS Of 194 LT recipients, 52 (27% of all patients, 42% of those tested) tested positive for 1 or more alcohol biomarkers at least once. Female sex and younger age, but not pre-LT sobriety duration, were identified as independent risk factors for biomarker-confirmed post-LT return to alcohol use. Survival analysis identified a shorter time to biomarker confirmed return to alcohol use for patients with <6 months (P<0.0001) and 6-12 months (P<0.0001) of pre-LT sobriety, compared with those with ≥12 months sobriety. However, patients with shorter pre-LT sobriety duration underwent biomarker testing significantly earlier following LT (P<0.0001). There was no difference in 1-year post-LT mortality between patients with <6 months and those with > 6-month pre-LT sobriety. CONCLUSIONS In this retrospective cohort study, we observed that 1-year mortality and biomarker-confirmed return to alcohol use outcomes were not affected by pre-LT sobriety duration, supporting evolving standards that favor individualized risk assessment over fixed abstinence periods.
Authors
- Ana Ivkovic
- Heidi Yeh (ORCID: https://orcid.org/0000-0002-7379-0600)
- Maria P. Diaz-Soto (ORCID: https://orcid.org/0000-0003-3713-8030)
- Mladen Nisavic (ORCID: https://orcid.org/0009-0006-9048-7212)
- Leigh Anne Dageforde (ORCID: https://orcid.org/0000-0001-9706-1771)
- Eric M. Przybyszewski (ORCID: https://orcid.org/0000-0001-5664-3361)
- Emily D. Bethea (ORCID: https://orcid.org/0000-0003-3759-8360)
- Sofia G. Baptista (ORCID: https://orcid.org/0009-0003-1208-247X)
- Kelly C. Hsu
- Katherine C. Specht
- Sienna D. Lila
- Wei Zhang
Institutions
- Tufts University (US)
- Beth Israel Deaconess Medical Center (US)
- University of Massachusetts Chan Medical School (US)
- University of Washington (US)
- Massachusetts General Hospital (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Annals of Transplantation
- Published
- 2026-11-17
- DOI
- https://doi.org/10.12659/aot.952998
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00